A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodie

Clinical and Experimental Rheumatology

Volumn 31, Issue SUPPL.76, 2013, Pages

  Cavazzana, Ilaria ^a   Fredi, Micaela ^b,c   Taraborelli, Mara ^b,c   Quinzanini, Marzia ^a   Tincani, Angela ^a,b   Franceschini, Franco ^a  

^a Rheumatology and Clinical Immunology Unit   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

Author keywords

Anti Ku antibody; Erythematosus; Myositis; Raynaud's phenomenon; Systemic lupus; Systemic sclerosis

Indexed keywords

AUTOANTIBODY; KU ANTIBODY; UNCLASSIFIED DRUG; HELICASE; XRCC5 PROTEIN, HUMAN;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; DISEASE ASSOCIATION; DYSPHAGIA; FEMALE; FINGER ULCER; FUNCTIONAL DISEASE; HUMAN; IMMUNOELECTROPHORESIS; INCIDENCE; INTERSTITIAL LUNG DISEASE; MALE; MYOSITIS; PRIORITY JOURNAL; RAYNAUD PHENOMENON; RETROSPECTIVE STUDY; SKIN DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; AGED; ANGIOSCOPY; BLOOD; EPIDEMIOLOGY; IMMUNOLOGY; MIDDLE AGED; RISK FACTOR;

ADULT; AGED; AUTOANTIBODIES; DNA HELICASES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MICROSCOPIC ANGIOSCOPY; MIDDLE AGED; MYOSITIS; RAYNAUD DISEASE; RISK FACTORS; SCLERODERMA, SYSTEMIC; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 84883773564     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. MIMORI T, AZIKUKI M, YAMAGATA H, INADA S, YOSHIDA S, HOMMA M: Characterization of a high molecular weight acidic nuclear protein recognised by autoantibodies from patients with polymyositis-scleroderma overlap. J Clin Invest 1981; 68: 611-20.
2. CAVAZZANA I, CERIBELLI A, QUINZANINI M et al.: Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases. Lupus 2008; 17: 727-32.
3. YANEVA M, ARNETT FC: Antibodies against Ku protein in sera from patients with autoimmune diseases. Clin Exp Rheumatol 1989; 76: 366-72.
4. RIGOLET A, MUSSET L, DUBOURG O et al.: Inflammatory myopathies with anti-Ku antibodies. Medicine 2012; 91: 95-102.
5. ROZMAN B, CUCNIK S, SODIN-SEMRL S et al.: Prevalence and clinical association of anti-ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multi-centre case-control study. Ann Rheum Dis 2008; 67: 1282-6.
6. MEDSGER TA, SILMAN AJ, STEEN VD et al.: A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 1999; 26: 2159-67.
7. CUTOLO M, SULLI A, PIZZORNI C, ACCARDO S: Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 2000; 27: 155-60.
8. ARNETT FC, HAMILTON RG, ROEBBER MG, HARLEY JB, REICHLIN M: Increased frequencies of Sm and nRNP autoantibodies in american blacks compared to whites with systemic lupus erythematosus. J Rheumatol 1988; 15: 1773-6.
9. WANG J, SATOH M, KABIR F et al.: Increased prevalence of autoantibodies to ku antigens in African American versus white patients with systemic lupus erythematosus. Arthritis Rheum 2001; 44: 2367-70.
10. HEIJNEN IA, FOOCHAROEN C, BANNERT B et al.: Clinical significance of coexisting antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis: a EUSTAR group-based study. Clin Exp Rheumatol 2013; 31 (Suppl. 76): S96-S102.
11. KOSCHIK RW 2nd, FERTIG N, LUCAS MR, DOMSIC RT, MEDSGER TA: Anti-PM-Scl antibody in patients with systemic sclerosis. Clin Exp Rheumatol 2012; 30: S12-6.
12. CARAMASCHI P, CANESTRINI S, MARTINELLI N et al.: Scleroderma patients nailfold videocapillaroscopic patterns are associated with disease subset and disease severity. Rheumatology (Oxford) 2007; 46: 1566-9.
13. SMITH V, DE KEYSER F, PIZZORNI C et al.: Nailfold capillaroscopy for day-to-day clinical use: construction of a simple scoring modality as a clinical prognostic index for digital trophic lesions. Ann Rheum Dis 2011; 70: 180-3.
14. SULLI A, SECCHI ME, PIZZORNI C, CUTOLO M: Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients. Ann Rheum Dis 2008; 67: 885-7.
15. PAVLOV-DOLIJANOVIC S, DAMJANOV NS, STOJANOVIC RM, VUJASINOVIC STUPAR NZ, STANISAVLJEVIC DM: Scleroderma pattern of nailfold capillary changes as predictive value for the development of a connective tissue disease: a follow-up study of 3,029 patients with primary Raynaud's phenomenon. Rheumatol Int 2012; 32: 3039-45.